Lymphoma, Follicular, Marginal Zone
1 clinical trials · Condition
◉ Watch Lymphoma, Follicular, Marginal Zone
| Record | Firm | Date |
|---|---|---|
| A Study of TAK-659 as a Single Agent in Adult East Asian Participants With Non-Hodgkin Lymphoma (NHL) (NCT03238651) | Calithera Biosciences, Inc | 2017-08-01 |
Track Lymphoma, Follicular, Marginal Zone automatically
Every clearance here is in the API, with alerts when new ones post.